Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haemophilia A and B”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01510418
What this trial is testing

Socialization of Adult Men With Congenital Hemophilia A or B

Who this might be right for
Hemophilia AHemophilia B
Dana-Farber Cancer Institute 27
Not applicableStudy completedNCT00581438
What this trial is testing

Study Evaluating Approach to Treatment of Haemophilia A and B in Spain

Who this might be right for
Hemophilia AHemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 52
Large-scale testing (Phase 3)Study completedNCT00141843
What this trial is testing

Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) With Advate (FLrFVIII) in Hemophilia A

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer 100
Large-scale testing (Phase 3)Study completedNCT03417245
What this trial is testing

Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 120
Large-scale testing (Phase 3)Study completedNCT03417102
What this trial is testing

Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 60
Testing effectiveness (Phase 2)Study completedNCT03370172
What this trial is testing

BAX 888 in Male Adults With Severe Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 4
Large-scale testing (Phase 3)Study completedNCT02053792
What this trial is testing

A Safety and Efficacy Extension Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B

Who this might be right for
Hemophilia B
CSL Behring 97
Large-scale testing (Phase 3)Looking for participantsNCT07545395
What this trial is testing

Safety of KN057 Prophylaxis in Patients With Haemophilia A or B

Who this might be right for
Hemophilia A or B
Suzhou Alphamab Co., Ltd. 70
Large-scale testing (Phase 3)Study completedNCT03587116
What this trial is testing

Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

Who this might be right for
Hemophilia BHemophilia A
Pfizer 212
Early research (Phase 1)Study completedNCT00956345
What this trial is testing

Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia B

Who this might be right for
Congenital Bleeding DisorderHaemophilia B
Novo Nordisk A/S 18
Early research (Phase 1)Study completedNCT01562457
What this trial is testing

Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding State

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 30
Early research (Phase 1)Study completedNCT01288391
What this trial is testing

Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B Patients

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 15
Not applicableUnknownNCT05981313
What this trial is testing

Viscoelastic Properties of Lower Extremity Muscles in Patients With Hemophilia

Who this might be right for
HemophiliaHemophilia AHemophilia B
Hasan Kalyoncu University 40
Testing effectiveness (Phase 2)Ended earlyNCT03641703
What this trial is testing

A Long-Term Follow-Up Study of Haemophilia B Patients Who Have Undergone Gene Therapy

Who this might be right for
Hemophilia B
Spur Therapeutics 10
Not applicableStudy completedNCT03185897
What this trial is testing

Global Epidemiologic Study of Preexisting Immunity to AAV in Adults With Severe Hemophilia

Who this might be right for
Hemophilia AHemophilia B
Baxalta now part of Shire 242
Early research (Phase 1)Study completedNCT05651061
What this trial is testing

A Phase I of SS109 in Hemophilia A or and B With Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia B With InhibitorFactor VII Deficiency
Hangzhou Gensciences Biopharmaceutical Co., Ltd. 27
Not applicableUnknownNCT04570696
What this trial is testing

TFPI Levels in Haemophilia A and B Patients

Who this might be right for
Haemophilia A and B
CHU de Reims 100
Testing effectiveness (Phase 2)Study completedNCT03489291
What this trial is testing

Dose Confirmation Trial of AAV5-hFIXco-Padua

Who this might be right for
Hemophilia B
CSL Behring 3
Not applicableNot Yet RecruitingNCT07657715
What this trial is testing

Effects of Dexmedetomidine on Sublingual Microcirculation and Vascular Waterfall Phenomenon in Patients With Septic Shock

Who this might be right for
Septic ShockSepsisCritical Illness
First Affiliated Hospital of Wannan Medical College 20
Not applicableStudy completedNCT03875547
What this trial is testing

Post-marketing Surveillance (Use Result Surveillance) With Refixia®

Who this might be right for
Haemophilia B
Novo Nordisk A/S 28
Next Page